juli raises $3.8 million

juli , a digital health platform for managing chronic conditions, closed a $3.8 million seed funding round.

Leading the round were Speedinvest, one of Europe’s most active early-stage venture capital firms, and Norrsken VC, a fund investing in startups solving the world’s biggest problems while building massive businesses.

SoftBank’s Vision Fund Emerge Program also joined the financing round.

Founded in 2020, the financing will enable juli to scale its commercial team across the US, conduct clinical trials of the app, and acquire additional AI talent.

“juli is helping patients, providers and employers identify behavioral triggers that worsen or improve the most hard-to-treat and complex chronic conditions, including asthma, migraines, depression, and bipolar disorder. With the support of Speedinvest, Norrsken, and our other investors, we will be able to expand our reach to improve patient health and lower health care costs.” – Bettina Hein, CEO, and co-founder of Boston-based juli.

Since launching a year ago, approximately 15,000 patients have used the juli app to track data for chronic, debilitating conditions.